The global ubiquinone market size was valued at $473.6 million in 2020, and is projected to reach $752.1 million by 2030, registering a CAGR of 4.8% from 2021 to 2030.

Ubiquinone which is also known as coenzyme Q10 (CoQ10) is naturally occurring vitamin-like substance which is present in animals, plants, and human body. In human body, it is found in heart, kidney, liver, and pancreas. Ubiquinone is also industrially manufactured by two production methods including microbial fermentation and chemical synthesis. Additionally, it is largely used in the treatment of heart conditions such as congestive heart failure and other diseases such as Huntington’s disease, breast cancer, gum diseases and others. It is commonly used in tablets, supplements, and capsules in pharmaceuticals and nutraceuticals industries.

Get more information on this report : Request Sample Pages

Coenzyme Q10 or ubiquinone is considered to be an immunity enhancing enzyme which helps in mitigating the possibility of disease like cancer. Additionally, the aging population is expected to provide lucrative opportunities for the expansion of cosmetic industry in the countries like Japan, Latin America and others. According to WHO, the population in Latin America is aging at a rapid pace. Thus, this in turn is likely to offer immense opportunity for the growth of ubiquinone market from the cosmetics industry during the ubiquinone forecast period in terms of value sales.

Covid-19 Impact Analysis

• The outbreak of the COVID-19 pandemic has shown a positive impact on the market. 
• During the COVID-19 outbreak, the nutraceutical industry got benefit from consumers who were looking to lead healthier lifestyles and improve their dietary habits and immune power due to this COVID-19. This in turn has boosted the demand for ubiquinone in the nutraceutical industry boosting the growth of overall market in this corona virus outbreak.

The global ubiquinone market is segmented are categorized into production method, application and region. By production method, it is classified into microbial fermentation and chemical synthesis. By application, it is divided into pharmaceuticals, dietary supplements and cosmetics. Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and rest of Europe), Asia-Pacific (China, Japan, India, Australia & New Zealand, South Korea, ASEAN and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Turkey and Rest of LAMEA).

By production method, the microbial fermentation segment accounted the highest ubiquinone market share in 2020. This is mainly attributed to its effectiveness in synthesizing ubiquinone through this method. Thus, contributing toward growth of the overall ubiquinone industry. However, the chemical synthesis production method is expected to be the fastest growing segment during the forecast period in terms of value sales.

[PRODUCTIONMETHODGRAPH]

Get more information on this report : Request Sample Pages

By application, the market is divided into dietary supplement, pharmaceuticals and cosmetics. In 2020, the dietary supplement segment accounted for the highest market share in the global ubiquinone market and is also expected to be the fastest growing segment during the forecast period. This is attributed to the various health benefits associated with the use of ubiquinone in the form of dietary supplement which has fueled its demand in the nutraceuticals industry. However, cosmetics segment in the ubiquinone market is expected to be the fastest growing segment during the forecast period in terms of value sales.

[APPLICATIONGRAPH]

Get more information on this report : Request Sample Pages

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the year 2020. The North America ubiquinone market dominated the use of ubiquinone, owing to the fact that the consumption of ubiquinone is increasing among the consumers in this region. This is mainly due to high incidences of diseases, such as, high cholesterol high blood pressure, coronary heart diseases, atherosclerosis, and congestive heart failures. Ubiquinone helps protect heart and blood vessels from getting damaged. Therefore, North America has created a prolific ubiquinone market demand over the period of time. However, Asia-Pacific is expected to be the fastest growing market during the market forecast period.

[REGIONGRAPH]

Get more information on this report : Request Sample Pages

Key players operating in the global ubiquinone market focus on prominent strategies to overcome competition and maintain as well as improve their share worldwide. Some of the major players in the global industry analyzed in this report include Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd., Kaneka Corporation, Kyowa Hakko Bio Co., Ltd., Oriental Yeast Co., Ltd., Shandong Octagon Chemicals Limited, Shenzhou Biology & Technology Co., Ltd., Sinoway Industrial Co., Ltd., Spectrum Chemical Manufacturing Corp., Tokiwa Phytochemical Co., Ltd. and Xiamen Kingdomway Group Company.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the current ubiquinone market trends, estimations, and dynamics of the global market for the period of 2020–2030 to identify the prevailing ubiquinone market opportunity.
• The key countries in four major regions have been mapped based on their market share.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
• In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region have been mapped according to their revenue contribution to the global industry. 
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of market players.
• The report includes both regional as well as global the ubiquinone market analysis, key players, market segments, application areas, and ubiquinone market growth strategies.

Key Market Segments

By Production method

• Microbial Fermentation
• Chemical Synthesis

By Application

• Dietary Supplements
• Pharmaceuticals
• Cosmetics

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Turkey 
  • Rest of LAMEA

 Key Market Segments

• By PRODUCTION METHOD
  • Microbial Fermentation
  • Chemical synthesis
• By APPLICATION
  • Dietary supplements
  • Pharmaceuticals
  • Cosmetics
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

 
Key Market Players

• SHANDONG OCTAGON CHEMICALS LIMITED
• SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.
• SINOWAY INDUSTRIAL CO., LTD.
• KYOWA HAKKO BIO CO., LTD.
• XIAMEN KINGDOMWAY GROUP COMPANY
• ORIENTAL YEAST CO., LTD.
• HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.
• TOKIWA PHYTOCHEMICAL CO., LTD.
• SPECTRUM CHEMICAL MANUFACTURING CORP.
• KANEKA CORPORATION

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.COVID-19 impact on ubiquinone market
3.5.Value chain Analysis
3.6.Top Impacting Factors
3.7.Parent Market Analysis
3.8.Market dynamics

3.8.1.Drivers

3.8.1.1.Rising adoption of ubiquinone in nutraceuticals industry
3.8.1.2.Growing usage of ubiquinone in cosmetic industry
3.8.1.3.Upsurge in the usage of ubiquinone in the Food Industry

3.8.2.Restraint

3.8.2.1.Lack of consumer awareness regarding availability of ubiquinone as a dietary supplement
3.8.2.2.Availability of counterfeit products

3.8.3.Opportunities

3.8.3.1.Rising usage of ubiquinone in pharmaceutical Industry
3.8.3.2.Rapid growth of online retail platform

CHAPTER 4:UBIQUINONE MARKET, BY PRODUCTION METHOD

4.1.Overview

4.1.1.Market size and forecast

4.2.Microbial Fermentation

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Chemical synthesis

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:UBIQUINONE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Dietary supplements

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country

5.3.Pharmaceuticals

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Cosmetics

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country

CHAPTER 6:UBIQUINONE MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by production method
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country

6.2.4.1.U.S.

6.2.4.1.1.Market size and forecast, by production method
6.2.4.1.2.Market size and forecast, by application

6.2.4.2.Canada

6.2.4.2.1.Market size and forecast, by production method
6.2.4.2.2.Market size and forecast, by application

6.2.4.3.Mexico

6.2.4.3.1.Market size and forecast, by production method
6.2.4.3.2.Market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by production method
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country

6.3.4.1.Germany

6.3.4.1.1.Market size and forecast, by production method
6.3.4.1.2.Market size and forecast, by Application

6.3.4.2.UK

6.3.4.2.1.Market size and forecast, by production method
6.3.4.2.2.Market size and forecast, by application

6.3.4.3.France

6.3.4.3.1.Market size and forecast, by production method
6.3.4.3.2.Market size and forecast, by Application

6.3.4.4.Italy

6.3.4.4.1.Market size and forecast, by production method
6.3.4.4.2.Market size and forecast, by application

6.3.4.5.Spain

6.3.4.5.1.Market size and forecast, by production method
6.3.4.5.2.Market size and forecast, by Application

6.3.4.6.Russia

6.3.4.6.1.Market size and forecast, by production method
6.3.4.6.2.Market size and forecast, by application

6.3.4.7.Rest of Europe

6.3.4.7.1.Market size and forecast, by production method
6.3.4.7.2.Market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by production method
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country

6.4.4.2.Japan

6.4.4.2.1.Market size and forecast, by production method
6.4.4.2.2.Market size and forecast, by application

6.4.4.3.India

6.4.4.3.1.Market size and forecast, by production method
6.4.4.3.2.Market size and forecast, by application

6.4.4.4.China

6.4.4.4.1.Market size and forecast, by production method
6.4.4.4.2.Market size and forecast, by application

6.4.4.5.Australia & New Zealand

6.4.4.5.1.Market size and forecast, by production method
6.4.4.5.2.Market size and forecast, by application

6.4.4.6.ASEAN

6.4.4.6.1.Market size and forecast, by production method
6.4.4.6.2.Market size and forecast, by application

6.4.4.7.South Korea

6.4.4.7.1.Market size and forecast, by production method
6.4.4.7.2.Market size and forecast, by application

6.4.4.8.Rest of Asia-Pacific

6.4.4.8.1.Market size and forecast, by production method
6.4.4.8.2.Market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by production method
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country

6.5.4.1.Brazil

6.5.4.1.1.Market size and forecast, by production method
6.5.4.1.2.Market size and forecast, by application

6.5.4.2.Saudi Arabia

6.5.4.2.1.Market size and forecast, by production method
6.5.4.2.2.Market size and forecast, by application

6.5.4.3.South Africa

6.5.4.3.1.Market size and forecast, by production method
6.5.4.3.2.Market size and forecast, by application

6.5.4.4.Turkey

6.5.4.4.1.Market size and forecast, by production method
6.5.4.4.2.Market size and forecast, by application

6.5.4.5.Rest of LAMEA

6.5.4.5.1.Market size and forecast, by production method
6.5.4.5.2.Market size and forecast, by application

6.6.Top Player Positioning
6.7.Competitive dashboard
6.8.Competitive heat map

CHAPTER 7:COMPANY PROFILES

7.1.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Product portfolio

7.2.KANEKA CORPORATION

7.2.1.Company overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business performance

7.3.KYOWA HAKKO BIO CO., LTD.

7.3.1.Company overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Product portfolio

7.4.ORIENTAL YEAST CO., LTD.

7.4.1.Company overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Product portfolio

7.5.SHANDONG OCTAGON CHEMICALS LIMITED

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Product portfolio

7.6.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Product portfolio

7.7.SINOWAY INDUSTRIAL CO., LTD.

7.7.1.Company overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Product portfolio

7.8.SPECTRUM CHEMICAL MANUFACTURING CORP.

7.8.1.Company overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Product portfolio

7.9.TOKIWA PHYTOCHEMICAL CO., LTD.

7.9.1.Company overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Product portfolio

7.10.XIAMEN KINGDOMWAY GROUP COMPANY

7.10.1.Company overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
7.10.5.1.DISCLAIMER

LIST OF TABLES

TABLE 01.UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 02.MICROBIAL FERMENTATION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 03.CHEMICAL SYNTHESIS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 04.UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 05.DIETARY SUPPLEMENTS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 06.PHARMACEUTICALS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 07.COSMETICS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 08.UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 09.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 10.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY APPLICATION , 2020-2030($MILLION)
TABLE 11.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 12.U.S. UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 13.U.S UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 14.CANADA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 15.CANADA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 16.MEXICO UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 17.MEXICO UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 18.EUROPE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 19.EUROPE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 20.EUROPE UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.GERMANY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 22.GERMANY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 23.UK UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 24.UK UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 25.FRANCE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 26.FRANCE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 27.ITALY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 28.ITALY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 29.SPAIN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 30.SPAIN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 31.RUSSIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 32.RUSSIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 33.REST OF EUROPE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 34.REST OF EUROPE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 35.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 36.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 37.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 38.JAPAN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 39.JAPAN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 40.INDIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 41.INDIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 42.CHINA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 43.CHINA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 44.AUSTRALIA & NEW ZEALAND UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 45.AUSTRALIA & NEW ZEALAND UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 46.ASEAN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 47.ASEAN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 48.SOUTH KOREA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 49.SOUTH KOREA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 50.REST OF ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 52.LAMEA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 53.LAMEA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 54.LAMEA UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55.BRAZIL UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 56.BRAZIL UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 57.SAUDI ARABIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 58.SAUDI ARABIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 59.SOUTH AFRICA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 60.SOUTH AFRICA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 61.TURKEY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 62.TURKEY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 63.REST OF LAMEA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 64.REST OF LAMEA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 65.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY SNAPSHOT
TABLE 66.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCT PORTFOLIO
TABLE 67.KANEKA CORPORATION: KEY EXECUTIVES
TABLE 68.KANEKA CORPORATION: COMPANY SNAPSHOT
TABLE 69.KANEKA CORPORATION: OPERATING SEGMENTS
TABLE 70.KANEKA CORPORATION: PRODUCT PORTFOLIO
TABLE 71.KANEKA CORPORATION: NET SALES, 2019–2020 ($MILLION)
TABLE 72.KYOWA HAKKO BIO CO., LTD.: KEY EXECUTIVES
TABLE 73.KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT
TABLE 74.KYOWA HAKKO BIO CO., LTD.: PRODUCT PORTFOLIO
TABLE 75.ORIENTAL YEAST CO., LTD.: KEY EXECUTIVES
TABLE 76.ORIENTAL YEAST CO., LTD.: COMPANY SNAPSHOT
TABLE 77.ORIENTAL YEAST CO., LTD.: PRODUCT PORTFOLIO
TABLE 78.SHANDONG OCTAGON CHEMICALS LIMITED: COMPANY SNAPSHOT
TABLE 79.SHANDONG OCTAGON CHEMICALS LIMITED: PRODUCT PORTFOLIO
TABLE 80.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 81.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
TABLE 82.SINOWAY INDUSTRIAL CO., LTD.: KEY EXECUTIVES
TABLE 83.SINOWAY INDUSTRIAL CO., LTD.: COMPANY SNAPSHOT
TABLE 84.SINOWAY INDUSTRIAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 85.SPECTRUM CHEMICAL MANUFACTURING CORP.: KEY EXECUTIVES
TABLE 86.SPECTRUM CHEMICAL MANUFACTURING CORP.: COMPANY SNAPSHOT
TABLE 87.SPECTRUM CHEMICAL MANUFACTURING CORP.: PRODUCT PORTFOLIO
TABLE 88.TOKIWA PHYTOCHEMICAL CO., LTD.: KEY EXECUTIVES
TABLE 89.TOKIWA PHYTOCHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 90.TOKIWA PHYTOCHEMICAL CO, LTD: PRODUCT PORTFOLIO
TABLE 91.XIAMEN KINGDOMWAY GROUP COMPANY: KEY EXECUTIVES
TABLE 92.XIAMEN KINGDOMWAY GROUP COMPANY: COMPANY SNAPSHOT
TABLE 93.XIAMEN KINGDOMWAY GROUP COMPANY: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.UBIQUINONE MARKET SNAPSHOT
FIGURE 02.UBIQUINONE MARKET: SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.HIGH BARGAINING POWER OF BUYER
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.HIGH THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.UBIQUINONE MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.UBIQUINONE MARKET, BY PRODUCTION METHOD, 2020 (%)
FIGURE 11.MICROBIAL FERMENTATION UBIQUINONE MARKET, COMPARATIVE COUNTRY MARKET SHARE ANALYSIS, 2020 AND 2030 (%)
FIGURE 12.CHEMICAL SYNTHESIS UBIQUINONE MARKET, COMPARATIVE REGIONAL MARKET SHARE ANALYSIS, 2020 AND 2030 (%)
FIGURE 13.UBIQUINONE MARKET, BY APPLICATION, 2020 (%)
FIGURE 14.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF DIETARY SUPPLEMENTS UBIQUINONE MARKET,2020 AND 2030 (%)
FIGURE 15.COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF PHARMACEUTICALS UBIQUINONE MARKET, 2020 AND 2030 (%)
FIGURE 16.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF COSMETICS UBIQUINONE MARKET,2020 AND 2030 (%)
FIGURE 17.UBIQUINONE MARKET, BY REGION, 2020 (%)
FIGURE 18.U.S. UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 19.CANADA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 20.MEXICO UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 21.GERMANY UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 22.UK UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 23.FRANCE UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 24.ITALY UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 25.GERMANY UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 26.RUSSIA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 27.REST OF EUROPE UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 28.JAPAN UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 29.INDIA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 30.CHINA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 31.AUSTRALIA & NEW ZEALAND UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 32.ASEAN UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 33.SOUTH KOREA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 35.BRAZIL UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 36.SAUDI ARABIA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 37.SOUTH AFRICA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 38.TURKEY UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 39.REST OF LAMEA UBIQUINONE MARKET REVENUE, 2020–2030 ($MILLION)
FIGURE 40.TOP PLAYER POSITIONING
FIGURE 41.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 43.KANEKA CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.KANEKA CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.KANEKA CORPORATION: REVENUE SHARE BY REGION, 2020 (%)